Literature DB >> 29782216

Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.

Warawut Laolerd1, Yukihiro Akeda2,3,4, Likit Preeyanon5, Panan Ratthawongjirakul6, Pitak Santanirand1.   

Abstract

AIM: The purpose of the study was to determine the epidemiology of carbapenemase genes among carbapenem-resistant Enterobacteriaceae and evaluate the Carba NP and modified carbapenem inactivation method (mCIM) tests in their detection.
MATERIALS AND METHODS: A total of 287 nonduplicated Enterobacteriaceae isolates, which were at least resistant to one of the carbapenems, were identified and detected for carbapenemase genes by multiplex PCR covering blaKPC, blaNDM, blaVIM, blaIMP, and blaOXA-48-like. All positive genes were then sequenced. These isolates were phenotypically tested for the production of carbapenemases by mCIM and Carba NP tests to evaluate the efficacy of these methods.
RESULTS: Seven species of carbapenem-resistant isolates mainly Klebsiella pneumoniae, Escherichia coli, and Enterobacter cloacae were detected. Of these isolates, three families of carbapenemase genes, including blaNDM (blaNDM-1, -4, -5, -9), blaOXA (blaOXA-48, -181, -232), and blaIMP-14, were found. Of these, 223 (77.70%) carried at least one of the carbapenemase genes. The blaNDM was detected in 160/223 (71.75%) isolates, of which 153/160 (95.63%) were the blaNDM-1. Three types of the blaOXA-48-like group, blaOXA-48, blaOXA-181, and blaOXA-232, were found, 91/104 (87.5%) harbored the blaOXA-232. In addition, 25.11% (56/223) of the carbapenemase-producing isolates harbored a combination of blaNDM and blaOXA-48-like. Phenotypic detection methods, mCIM and Carba NP, showed 100% sensitivity and specificity to blaNDM, blaIMP-14, and blaOXA-48, while the mCIM was positive in all blaOXA-181 and blaOXA-232 isolates, only 12.5% (1/8) and 28.95% (11/38), respectively, were detected by the Carba NP test.
CONCLUSIONS: This study revealed a unique prevalence of carbapenemase genes in Bangkok, Thailand, as well as demonstrated the efficacy and limitation of phenotypic detection methods of carbapenemase in the area where blaNDM-1 and blaOXA-232 were predominant.

Entities:  

Keywords:  CRE; Carba NP test; OXA-181; OXA-232; mCIM

Mesh:

Substances:

Year:  2018        PMID: 29782216     DOI: 10.1089/mdr.2018.0080

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  17 in total

Review 1.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

2.  Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales.

Authors:  Korawan Pudpong; Sutthiporn Pattharachayakul; Wichai Santimaleeworagun; Ozioma F Nwabor; Varaporn Laohaprertthisan; Thanaporn Hortiwakul; Boonsri Charernmak; Sarunyou Chusri
Journal:  Infect Drug Resist       Date:  2022-06-13       Impact factor: 4.177

Review 3.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

4.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 5.  Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects.

Authors:  Shio-Shin Jean; Nan-Yao Lee; Hung-Jen Tang; Min-Chi Lu; Wen-Chien Ko; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

6.  Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital.

Authors:  Darunee Chotiprasitsakul; Sirawat Srichatrapimuk; Suppachok Kirdlarp; Alexander D Pyden; Pitak Santanirand
Journal:  Infect Drug Resist       Date:  2019-02-20       Impact factor: 4.003

7.  Genomic characterization of an emerging blaKPC-2 carrying Enterobacteriaceae clinical isolates in Thailand.

Authors:  Anusak Kerdsin; Saowarat Deekae; Sunee Chayangsu; Rujirat Hatrongjit; Peechanika Chopjitt; Dan Takeuchi; Yukihiro Akeda; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

8.  Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.

Authors:  Wantana Paveenkittiporn; Meghan Lyman; Caitlin Biedron; Nora Chea; Charatdao Bunthi; Amy Kolwaite; Noppavan Janejai
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-05       Impact factor: 4.887

9.  The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital.

Authors:  Worapong Nasomsong; Parnrada Nulsopapon; Dhitiwat Changpradub; Manat Pongchaidecha; Supanun Pungcharoenkijkul; Piraporn Juntanawiwat; Waristha Simsiriporn; Wichai Santimaleeworagun
Journal:  Drug Des Devel Ther       Date:  2021-07-16       Impact factor: 4.162

10.  Multidrug-Resistant and Carbapenemase-Producing Enterobacteriaceae in Addis Ababa, Ethiopia.

Authors:  Saba Gebremichael Tekele; Dejenie Shiferaw Teklu; Melese Hailu Legese; Daniel Gebretsadik Weldehana; Melaku Ashagrie Belete; Kassu Desta Tullu; Samuel Kinde Birru
Journal:  Biomed Res Int       Date:  2021-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.